THIRD INTERNATIONAL GENE THERAPY OF CANCER CONFERENCE

拟议中的会议是第三次致力于 癌症的基因治疗。来自世界各地的顶尖研究人员将 介绍他们的临床前和临床研究的最新结果 利用基因治疗技术治疗癌症。该计划将包括 在两天半的时间里进行了五次半天的训练。重点将放在 耐药与敏感基因治疗、抑癌基因与抗肿瘤药物 癌基因治疗、细胞因子和肿瘤免疫治疗。每个主题会议 将从该领域的概述和人类的现状开始 临床试验。被邀请的演讲者之后将介绍以下内容 提供了描述最新临床和临床前数据的摘要。 每节课后将进行小组讨论。会有一个下午 致力于提交的其他口头和海报演示文稿 摘要。 这次会议将引起临床肿瘤学家的兴趣，分子 生物学家、细胞生物学家、肿瘤免疫学家和其他感兴趣的人 在这一领域工作的卫生专业人员和研究人员。 本次会议继续关注以下领域的重大发展： 人类癌症基因治疗的临床应用。

The proposed conference is the third international conference devoted to Gene Therapy of Cancer. Leading researchers from around the world will present the latest results of their pre-clinical and clinical studies of cancer treatment using gene therapy technology. The program will consist of five half-day sessions over a 2 1/2 day period. The focus will be on drug resistance and sensitivity gene therapy, tumor suppressor and anti- oncogene therapy and cytokine and tumor immunotherapy. Each topic session will begin with an overview of the field and the current status of human clinical trials. Invited speakers will be followed by the presentation of proffered abstracts describing recent clinical and pre-clinical data. Panel discussions will follow each session. There will be an afternoon devoted to additional oral and poster presentations from submitted abstracts. This conference will be of interest to clinical oncologists, molecular biologists, cellular biologists, tumor immunologists and other interested health professionals and researchers working in this field. This conference continues to focus on the major developments in field of human gene therapy for clinical use in cancer.